FEDERAL COURT OF AUSTRALIA
Apotex Pty Ltd v Les Laboratoires Servier (No 4)
[2015] FCA 104
Citation: Apotex Pty Ltd v Les Laboratoires Servier (No 4) [2015] FCA 104 Parties: APOTEX PTY LTD ACN 096 916 148 v LES LABORATOIRES SERVIER, SERVIER LABORATORIES (AUST) PTY LTD and ACTAVIS PTY LIMITED ACN 003 854 626 File number: NSD 51 of 2012 Judge: RARES J Date of judgment: 23 February 2015 Catchwords: PATENTS – amendment of patent under s 105 of the Patents Act 1990 (Cth) – requirement in s 40(2)(a) of the Patents Act 1990 (Cth) that patentee disclose best method of performing invention known to it – application by patentee after trial to amend complete specification to add a best method that court found patentee knew of at time of filing of complete specification – delay in applying for amendment of patent after pleadings raised non-compliance with s 40(2)(a) – whether complete specification can be amended after patent application filed – whether complete specification can be amended after patent granted –whether belief of patentee or other state of mind falling short of knowledge of a method requires patentee to disclose that as best method known to it pursuant to requirement in s 40(2)(a)
PATENTS – amendment of patent under s 105 of the Patents Act 1990 (Cth) – extent of patentee’s obligation to fully disclose all relevant matters in respect of application to amend patent – whether obligation limited to patentee’s reasons for amendment or extends to all issues relevant to validity of patent if amended as sought – whether earlier decision of patentee not to include subject matter of subsequent amendment application relevant to discretion to grant amendment under s 105
Legislation: Federal Court Rules 2011 (Cth)
Intellectual Property Laws Amendment (Raising the Bar) Act 2012 (Cth)
Patents Act 1990 (Cth)
Patents Amendment (Innovation Patents) Act 2000 (Cth)
Patent Cooperation Treaty 1970Cases cited: Alcan (NT) Alumina Pty Ltd v Commissioner of Territory Revenue (2009) 239 CLR 27
Alphapharm Pty Ltd v H Lundbeck A/S (2014) 314 ALR 182
Apotex Pty Ltd v Les Laboratoires Servier (No 3) [2014] FCA 1029
Apotex Pty Ltd v Les Laboratoires Servier [2013] FCA 1426
Australian Securities & Investments Commission v Hellicar (2012) 247 CLR 345
Australian Securities and Investments Commission v DB Management Pty Ltd (2000) 199 CLR 321
Bass v Permanent Trustee Co Ltd (1999) 198 CLR 334
Bayer Pharma Aktiengesellschaft v Generic Health Pty Ltd (2012) 99 IPR 59
Blair v Curran (1939) 62 CLR 464
Campbell v Backoffice Investments Pty Ltd (2009) 238 CLR 304
Commissioner for Railways (NSW) v Agalianos (1955) 92 CLR 390
CSL Ltd v Novo Nordisk Pharmaceuticals Pty Ltd (No 2) (2010) 190 FCR 522
Eli Lilly & Co v Barr Laboratories Inc 222 F 3d 973 (2000)
Federal Commissioner of Taxation v Consolidated Media Holdings Ltd (2012) 250 CLR 503
George v Rockett (1990) 170 CLR 104
Illinois Tool Works Inc v Autobars Co (Services) Ltd [1972] FSR 67
Jones v Dunkel (1959) 101…
Keep reading for free
Create a free CaseChat account to read Apotex Pty Ltd v Les Laboratoires Servier (No 4) and more:
- Read every judgment in full
- Ask AI and get answers linked to paragraphs
- See how each paragraph was cited in later cases
- Download judgments as PDF or Word
One click creates your free account or signs you in.
By continuing you agree to the Terms and Privacy Policy.
- Case
- [2015] FCA 104
- Decision Date
CaseChat Overview and Summary
The court addressed several legal issues. Firstly, it examined the timing and reasonableness of Servier's application for amendment, considering the delay in applying for the amendment after the non-compliance with section 40(2)(a) was raised. Secondly, the court deliberated on the public interest versus the patentee's interest in maintaining the patent, assessing whether Servier's failure to disclose the best method outweighed its proprietary interest. Thirdly, the court considered the scope of the patentee's obligation to disclose all relevant matters, including whether earlier decisions not to include certain subject matter in the original application affected the discretion to grant the amendment.
The court concluded that Servier's failure to disclose the 1986 and 1991 methods in the complete specification, despite knowing about them, was not reasonable and significantly harmed the public interest. This damage outweighed Servier's interest in saving the patent from revocation. Consequently, the court denied Servier's application to amend the patent, leading to the revocation of the patent on the grounds that the specification did not comply with section 40(2)(a) of the Act. The court ordered that the patent be amended by deleting certain claims, but dismissed the application otherwise. Additionally, the court directed the parties to provide written submissions regarding the costs of the trial and amendment application, reflecting the extensive nature of the proceedings.
The court's decision underscores the importance of timely and accurate disclosure in patent applications, balancing the interests of the patentee with the broader public interest. The outcome also highlights the court's discretion in allowing patent amendments, considering factors such as the timing of the application and the public interest in full disclosure.
Orders
Orders of the court
1. Until further order the publication of the reasons for judgment published in this matter today (the reasons) (but not these orders) be limited to:
(a) the respondents;
(b) the legal representatives of the applicant and the opponent who acted on the amendment application.
2. On or before 25 February 2015 each party identify any information in the reasons that is confidential, or that the party contends is confidential, and inform the associate to Rares J thereof.
3. The parties bring in short minutes of order on or before 25 February 2015 to give effect to these reasons.
4. The proceedings stand over for directions to 9.30 am on 12 March 2015.
Note: Entry of orders is dealt with in Rule 39.32 of the Federal Court Rules 2011.
Background
Background to the litigation
Full text does not contain this section.
Evidence
Evidence Before The Court
Full text does not contain this section.
Decision
Reasons for decision
Ratio Decidendi
Legal Principle Established
The opponents argued that, not only had Servier done nothing to seek an amendment after Apotex had first raised its best method ground in mid-March 2013 until my principal reasons were delivered on 24 December 2013, but it had delayed filing its application for some time after that decision and, initially, had not sought to include in the amendment the statement that each of the 1986 and 1991 methods had resulted in a white crystalline product. They submitted that Servier had caused disadvantage to the public by depriving it of the knowledge of the 1986, 1991 and 2002 methods for the period between the filing of the complete specification until late 2013, during which time Servier had subsequently filed the patents claiming various crystalline forms and methods for producing them referred to in [82] above. Moreover, the opponents argued that Servier had not put on evidence that its proposed amendments would actually disclose the best method known to it as at 27 February 2003, as opposed to that disclosure simply amounting to what Servier had chosen to reveal to deal with what Servier was aware that the opponents knew from the forensic process.(4) The discretion issue – the scope of the discretion under s 105(1) – consideration It is common ground that Servier’s proposed amendments are not precluded from allowance by ss 102 and 105(4). As I have explained above, the discretion conferred by s 105(1) is unconfined by implications or limitations that are not part of the grant of power when read with s 102. Nonetheless, in exercising the discretion under s 105(1) the Court must act judicially, mindful that the grant or rejection of an amendment may affect not just the rights and liabilities of the patentee and the other parties in the relevant litigation, but also those of the public at large. The words and other descriptions used in a patent are chosen by the original applicant who, generally, will become the patentee. The choices of those words and descriptions do not involve a process such as that in the negotiation of a contract in which two or more parties express what is ultimately a common outcome, usually reached after compromises of various positions. Thus, when a patentee applies to amend the terms of the document originally put forward as the basis for the State granting the patentee a limited monopoly, the circumstances surrounding the patentee’s decision to make the application in that form, ordinarily, will be relevant to the Court’s consideration of whether the patentee should be allowed to depart from what he, she or it originally wrote to express the extent of the monopoly sought. The Act does not evince any particular approach or predisposition as to how the Court should exercise its discretion to permit an amendment to a patent that is otherwise allowable, except to the extent that the occasion for the exercise of the power in s 105 necessarily will be in proceedings in which questions of revocation, infringement or validity of the patent are in issue.